bioAffinity Technologies (BIAF) Return on Sales (2022 - 2025)
Historic Return on Sales for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to 3.49%.
- bioAffinity Technologies' Return on Sales fell 26400.0% to 3.49% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.17%, marking a year-over-year decrease of 12700.0%. This contributed to the annual value of 0.97% for FY2024, which is 21700.0% up from last year.
- Per bioAffinity Technologies' latest filing, its Return on Sales stood at 3.49% for Q3 2025, which was down 26400.0% from 3.2% recorded in Q2 2025.
- Over the past 5 years, bioAffinity Technologies' Return on Sales peaked at 0.82% during Q1 2024, and registered a low of 4277.79% during Q3 2022.
- In the last 4 years, bioAffinity Technologies' Return on Sales had a median value of 3.35% in 2025 and averaged 488.01%.
- Examining YoY changes over the last 5 years, bioAffinity Technologies' Return on Sales showed a top increase of 42701100bps in 2023 and a maximum decrease of -207400bps in 2023.
- Over the past 4 years, bioAffinity Technologies' Return on Sales (Quarter) stood at 713.8% in 2022, then surged by 100bps to 1.07% in 2023, then fell by -25bps to 1.34% in 2024, then plummeted by -160bps to 3.49% in 2025.
- Its last three reported values are 3.49% in Q3 2025, 3.2% for Q2 2025, and 1.44% during Q1 2025.